FDA approved radioactive drugs

Ended Awarded

Contract number
75N90021F00002
Awardee
Awarding agency
Obligated
$100,000

Award facts

Contract value 100% obligated
$100,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Dublin, OH 43017, USA

Award details come from SAM.gov/FPDS.

About this award

Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a $100,000 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Health and Human Services' National Institutes of Health Clinical Center. The delivery order is for the provision of FDA-approved radioactive drugs to the agency through September 30, 2021. No set-aside designation was applied to this award. Cardinal Health 414 will supply the radioactive pharmaceuticals from its Dublin, Ohio facility to support research and care activities at the NIH Clinical Center, the clinical research hospital of the NIH.

Quick answers

Who was awarded contract 75N90021F00002?

75N90021F00002 was awarded to Cardinal Health 414, LLC by NIH Clinical Center (National Institutes of Health) on February 9, 2021.

How much is contract 75N90021F00002 worth?

The government has obligated $100,000 on 75N90021F00002.

Is contract 75N90021F00002 an order under another contract?

Yes. 75N90021F00002 is a delivery order under 75N90021D00002, an indefinite delivery contract.

Was contract 75N90021F00002 competed?

The extent of competition for 75N90021F00002 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award